Ignite Creation Date:
2025-12-24 @ 10:49 PM
Ignite Modification Date:
2026-05-01 @ 11:06 PM
Study NCT ID:
NCT04697069
Status:
TERMINATED
Last Update Posted:
2025-09-22
First Post:
2020-12-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform Rash
Sponsor:
Vanda Pharmaceuticals
Organization: